Sezer A - Search Results

1

The efficacy of immunotherapy and chemoimmunotherapy in patients with advanced rare tumors: A Turkish oncology group (TOG) study.

Guven DC, Aykan MB, Muglu H, Bayram E, Helvaci K, Dursun B, Celayir M, Chelebiyev E, Nayir E, Erman M, Sezer A, Urun Y, Demirci U, Er O, Disel U, Bilici A, Arslan C, Karadurmus N, Kilickap S. Guven DC, et al. Among authors: sezer a. Cancer Med. 2023 Dec 22;13(1):e6869. doi: 10.1002/cam4.6869. Online ahead of print. Cancer Med. 2023. PMID: 38140782 Free PMC article.

2

Promising efficacy of sorafenib in a relapsed thymic carcinoma with C-KIT exon 11 deletion mutation.

Dişel U, Oztuzcu S, Beşen AA, Karadeniz C, Köse F, Sümbül AT, Sezer A, Nursal GN, Abalı H, Ozyılkan O. Dişel U, et al. Among authors: sezer a. Lung Cancer. 2011 Jan;71(1):109-12. doi: 10.1016/j.lungcan.2010.09.011. Lung Cancer. 2011. PMID: 20970876

3

Effectiveness of percutaneous metal stent placement in cholangiocarcinoma patients with midterm follow-up: Single center experience.

Kose F, Oguzkurt L, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Mertsoylu H, Ozyilkan O. Kose F, et al. Among authors: sezer a. Eur J Radiol. 2012 Aug;81(8):1724-7. doi: 10.1016/j.ejrad.2011.04.056. Epub 2011 May 18. Eur J Radiol. 2012. PMID: 21596502

4

Weekly cisplatin versus standard three-weekly cisplatin in concurrent chemoradiotherapy of head and neck cancer: the Baskent University experience.

Kose F, Besen A, Sumbul T, Sezer A, Karadeniz C, Disel U, Altundag O, Ozyilkan O. Kose F, et al. Among authors: sezer a. Asian Pac J Cancer Prev. 2011;12(5):1185-8. Asian Pac J Cancer Prev. 2011. PMID: 21875263 Free article.

5

Patients with advanced cholangiocarcinoma benefit from chemotherapy if they are fit to receive it: single center experience.

Kose F, Abali H, Sezer A, Ali Besen A, Taner Sumbul A, Karadeniz C, Disel U, Ozyilkan U. Kose F, et al. Among authors: sezer a. J BUON. 2011 Jul-Sep;16(3):469-72. J BUON. 2011. PMID: 22006752

6

Prevalence of thyroid dysfunction in untreated cancer patients: a cross-sectional study.

Dişel U, Beşen A, Karadeniz C, Mertsoylu H, Sezer A, Köse F, TanerSümbül A, Gürkut O, Muallaoğlu S, Abali H, Ozyilkan O. Dişel U, et al. Among authors: sezer a. Med Oncol. 2012 Dec;29(5):3608-13. doi: 10.1007/s12032-012-0254-4. Epub 2012 May 22. Med Oncol. 2012. PMID: 22729367

7

Which patients with advanced cancer and biliary obstruction benefit from biliary stenting most? An analysis of prognostic factors.

Abali H, Sezer A, Oğuzkurt L, Gürel K, Özkan U, Beşen AA, Sümbül AT, Köse F, Dişel U, Muallaoğlu S, Özyılkan Ö. Abali H, et al. Among authors: sezer a. Support Care Cancer. 2013 Apr;21(4):1131-5. doi: 10.1007/s00520-012-1636-z. Epub 2012 Nov 8. Support Care Cancer. 2013. PMID: 23132146

8

Can serial monitoring of serum Vascular Endothelial Growth Factor (VEGF), Nitric Oxide (NO), and Angiotensin II (ANGII) levels have predictive role during Bevacizumab treatment?

Sümbül AT, Dişel U, Sezgin N, Sezer A, Köse F, Beşen AA, Sümbül Z, Abalı H, Özyılkan Ö. Sümbül AT, et al. Among authors: sezer a. Med Sci Monit. 2014 Mar 15;20:428-33. doi: 10.12659/MSM.889945. Med Sci Monit. 2014. PMID: 24632679 Free PMC article.

9

Cutaneous melanoma in Turkey: analysis of 1157 patients in the Melanoma Turkish Study.

Abali H, Celik I, Karaca B, Turna H, Kaytan Saglam E, Akman T, Oztop I, Senol Coskun H, Serdar Turhal N, Sezer A, Nayir E, Arican A, Ozkan M, Sevinc A, Demir G, Budakoglu B, Issikdogan A, Engin H, Kilickap S, Coskun U, Oyan B, Harputluoglu H, Er O, Kavgaci H, Elk Ran T. Abali H, et al. Among authors: sezer a. J BUON. 2015 Jul-Aug;20(4):1137-41. J BUON. 2015. PMID: 26416068

10

Prognostic factors for survival in patients with metastatic malign melanoma treated with ipilimumab: Turkish Oncology Group study.

Urun Y, Yasar HA, Turna H, Esin E, Sedef AM, Alkan A, Oksuzoglu B, Ozdemir N, Sendur MN, Sezer A, Kılıckap S, Utkan G, Akman T, Akbulut H, Celik I, Abalı H. Urun Y, et al. Among authors: sezer a. J Oncol Pharm Pract. 2019 Oct;25(7):1658-1664. doi: 10.1177/1078155218805539. Epub 2018 Nov 6. J Oncol Pharm Pract. 2019. PMID: 30400750

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

194 results

Search Page